Abstract
A study is overpowered if there is such a large sample size that small, clinically meaningless differences can be detected statistically. Studies should be planned to detect differences that are clinically meaningful to patients and providers.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Reference
Moore MJ, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 2007;25(15):1960–6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Cohen, A.L. (2023). Overpowering. In: Problems and Pitfalls in Medical Literature. Springer, Cham. https://doi.org/10.1007/978-3-031-40295-1_17
Download citation
DOI: https://doi.org/10.1007/978-3-031-40295-1_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-40294-4
Online ISBN: 978-3-031-40295-1
eBook Packages: MedicineMedicine (R0)